Mycotopia Therapies Acquires AI Robotics Assets with a Total Transaction Value of $9 Million
December 04, 2023 08:30 ET
|
Mycotopia Therapies Inc.
MIAMI, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (“Mycotopia Therapies”) (“the Company”) (OTC: TPIA) announced today it has purchased certain assets of Philon Labs, LLC ("Philon...
PSLY.com, Inc. Ei.Ventures, Inc. and Mycotopia Therapies Inc. Terminate Agreement and Plan of Merger
February 21, 2023 16:37 ET
|
Mycotopia Therapies Inc.
MIAMI and MAUI, Hawaii, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Ei.Ventures, Inc. (Ei.Ventures) and Mycotopia Therapies Inc. (“Mycotopia Therapies”)(OTC: TPIA) announced today that on February 16,...
Emotional Intelligence Ventures and Mycotopia enter a Definitive Agreement on $382M merger transaction
May 19, 2022 12:07 ET
|
Mycotopia Therapies Inc.
MIAMI and MAUI, Hawaii, May 19, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of...
Mycotopia Therapies Inc. Update on Ei.Ventures and Strategic Investments
May 09, 2022 08:30 ET
|
Mycotopia Therapies Inc.
MIAMI, May 09, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA), a biopharma company focused on research, technology, and the development of medical psychedelics, and Ei.Ventures...
Mycotopia Therapies Partners with Public Policy Specialist PsychedelicsEUROPE to Explore Opportunities in the European Market
May 02, 2022 08:30 ET
|
Mycotopia Therapies Inc.
MIAMI, May 02, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical psychedelics,...
Mycotopia Therapies Inc. To Enter $13 Billion Medicinal Mushroom Market With HAVN Life Sciences' Biopharmaceuticals And Ei.Ventures MANA Products
March 21, 2022 08:30 ET
|
Mycotopia Therapies Inc.
MIAMI, March 21, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical psychedelics,...
Mycotopia Therapies, Inc. Expands Presence In The Registered Mushroom Sector With HAVN Life Sciences Inc.
March 17, 2022 08:51 ET
|
Mycotopia Therapies Inc.
MIAMI, March 17, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical psychedelics,...
Mycotopia Therapies Announces Ei.Ventures Acquires 12x12 Estate in The Sandbox in Anticipation of PSLY.COM Launch Post-Merger with Mycotopia Therapies in Q1 2022
January 06, 2022 10:30 ET
|
Mycotopia Therapies Inc.
MIAMI, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical psychedelics,...
Mycotopia and Ei.Ventures sign LOI to Explore Merger and Formation of PSLY.COM, a $360 Million Transaction, And Will Apply To List Shares On NASDAQ
December 07, 2021 15:03 ET
|
Mycotopia Therapies Inc.
MIAMI, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical psychedelics,...
Mycotopia Therapies Announces Plan to Develop Psychedelic Sublingual Tablet to Help Treat Depression
November 17, 2021 08:30 ET
|
Mycotopia Therapies Inc.
MIAMI, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Mycotopia Therapies Inc. (OTC Pink: TPIA) (the “Company”), a biopharma company focused on research, technology, and the development of medical psychedelics,...